Status:
COMPLETED
Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Israeli association for lung disease
Conditions:
Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy. This study aimed to investigate the impact of long-term systemic st...
Eligibility Criteria
Inclusion
- For inclusion, a scheduled therapy with a minimum daily dose of 10 mg prednisone (or equivalent) for at least 3 months was required
Exclusion
- Patients younger than 18 years and those with known sleep apnea or other forms of sleep-disordered breathing were excluded
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
End Date :
January 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01228695
Start Date
January 1 2007
End Date
January 1 2010
Last Update
October 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam health care campus
Haifa, Israel, 31096